Skip to content

The behaviour of the drug tacrolimus in the stomach of healthy volunteers

Supersaturation and precipitation of tacrolimus in the stomach of healthy volunteers

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2016-002519-17-BE
Enrollment
Unknown
Registered
2016-07-26
Start date
2016-09-12
Completion date
Unknown
Last updated
2017-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy human volunteers , investigation of the drug's supersaturation behaviour in the stomach

Interventions

Trade Name: Prograft Product Name: Prograft Pharmaceutical Form: Capsule, hard INN or Proposed INN: TACROLIMUS CAS Number: 104987-11-3 Current Sponsor code: FK-506 Other descriptive name: Tacrolimus C

Sponsors

KU Leuven - Drug Delivery and Disposition
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - healthy volunteers- age: 18 - 35 years old Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 5 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - disease- acute/chronic GI condition- use of medication- pregnancy- frequent exposure to X-rays during the past year- HIV / HBV / HCV infection

Design outcomes

Primary

MeasureTime frame
Main Objective: Study the gastric behaviour of tacrolimus in healthy volunteers in fasted and fed state and when co-ingested with other beverages than water.;Secondary Objective: Non applicable;Primary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: Not applicable

Secondary

MeasureTime frame
Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: Not applicable

Countries

Belgium

Contacts

Public ContactDrug Delivery and Disposition

KU Leuven

jari.rubbens@kuleuven.be+3216377307

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026